- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 57.5M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $247M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $435.1M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $306.7M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.76B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.64B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $659.5M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $543.4M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $862.9M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.37B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.4B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.62B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.64B |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $136.5M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $125.5M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 58.1M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $11.7M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.12 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.14 |
| Net Income | Q1 2025 · Mar 31, 2024 | $64.8M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $81.3M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $303.4M |